OXFORD BIODYNAMICS PLC
Develops and commercializes precision medicine tests for oncology using 3D genomics.
OBD | IL
Overview
Corporate Details
- ISIN(s):
- GB00BD5H8572 (+2 more)
- LEI:
- 2138005Y1TK258O5U928
- Country:
- United Kingdom
- Address:
- 3140 ROWAN PLACE, JOHN SMITH DRIVE, OX4 2WB OXFORD
Description
Oxford BioDynamics PLC is a global biotechnology company advancing personalized healthcare by developing and commercializing precision medicine tests. The company's proprietary EpiSwitch® platform utilizes 3D genomics and epigenetic biomarkers to create diagnostic solutions for life-changing diseases, with a focus on oncology. Its portfolio of clinical tests includes the EpiSwitch® PSE, a blood test that assesses the likelihood of prostate cancer with high accuracy to help reduce unnecessary biopsies, and the EpiSwitch® CiRT, a test designed to predict a patient's therapeutic response to Immune Checkpoint Inhibitor cancer therapies. The platform enables the translation of 3D genome regulation into clinical applications for precision medicine at scale.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-09 13:50 |
Notice of Results
|
English | 13.1 KB | ||
| 2025-12-03 08:20 |
Statement re share price, update on EpiSwitch PSE
|
English | 12.9 KB | ||
| 2025-11-25 15:15 |
Holding(s) in Company
|
English | 21.2 KB | ||
| 2025-11-12 08:30 |
Holding(s) in Company
|
English | 40.0 KB | ||
| 2025-11-11 15:25 |
Holding(s) in Company
|
English | 21.0 KB | ||
| 2025-11-11 15:25 |
Holding(s) in Company
|
English | 51.1 KB | ||
| 2025-11-11 15:20 |
Holding(s) in Company
|
English | 51.0 KB | ||
| 2025-11-10 08:25 |
PDMR Dealing / Grant of Share Options
|
English | 64.7 KB | ||
| 2025-11-07 12:45 |
Result of General Meeting/PDMR Dealings
|
English | 60.6 KB | ||
| 2025-10-22 08:00 |
Fundraising, Posting of Circular & Notice of GM
|
English | 81.9 KB | ||
| 2025-10-14 08:00 |
OBD in New Report on NHS Prostate Cancer Screening
|
English | 16.0 KB | ||
| 2025-09-10 08:00 |
Holding(s) in Company
|
English | 22.1 KB | ||
| 2025-09-04 11:00 |
Study confirms clinical utility of EpiSwitch CiRT
|
English | 19.2 KB | ||
| 2025-08-13 08:00 |
Collaboration with Google Cloud
|
English | 12.0 KB | ||
| 2025-07-18 16:11 |
Holding(s) in Company
|
English | 21.9 KB |
Automate Your Workflow. Get a real-time feed of all OXFORD BIODYNAMICS PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for OXFORD BIODYNAMICS PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for OXFORD BIODYNAMICS PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
